Since the 1980s, percutaneous balloon coronary angioplasty (PTCA) and coronary stenting (PCI) have been widely used worldwide and have become the mainstay of treatment for coronary artery disease, especially for acute myocardial infarction. With the continuous improvement of people’s living standards in China, the number of patients with high blood pressure, high blood pressure, diabetes, smoking and other risk factors for coronary heart disease is increasing, coronary heart disease is increasingly becoming the primary “killer” endangering the health of our people, PCI (commonly known as “heart stent While PCI (commonly known as “heart stent”) is being promoted, there are many questions from patients, such as “Do I need a heart stent?” For example, “I heard from others that it is better to put in stents than not to put in stents”, “Why did I put in 3 stents when others only put in 1?”, “How many years do your stents last? “How many years do your stents last? What should we do if it is blocked again?” and so on, we often hear these questions. To answer these questions, the word “standardization” is indispensable. Yuan Jiansong, Department of Cardiovascular Medicine, Fu Wai Hospital, Beijing, has established strict clinical pathways and treatment guidelines on the indications for PCI (cardiac stenting) and the technical specifications of the National Health Planning Commission and the Cardiovascular Disease Branch of the Chinese Medical Association. Fu Wai Hospital of the Chinese Academy of Medical Sciences (Fu Wai, Beijing), as the national cardiovascular center and the mega heart center with the highest number of PCI cases in the world, is a model for standardized PCI treatment. Due to its remarkable strengths in medical care, research, teaching, and prevention, the Department of Cardiology and Department of Cardiac Surgery at Fu Wai, Beijing, was continuously ranked first in the prestigious Fudan University School of Medicine National Hospital Specialty Rankings from 2011 to 2013. In many competitions organized by the National Health Planning Commission and Beijing Municipality, they have been ranked as “the lowest single-patient hospitalization cost”, “the lowest mortality rate for routine PCI (cardiac stenting)” and “the lowest mortality rate for emergency PCI”. “These are the “hard indicators” that are most relevant to patients. In order to achieve these results, Beijing Fu Wai has focused on three aspects: First, in accordance with the requirements of the National Health Planning Commission and the Chinese Medical Association, we strictly select the indications for PCI (cardiac stent) before the operation, and develop an individualized treatment plan for each patient according to the patient’s systemic condition and cardiac characteristics; second, we lean during the PCI operation. operation, “treating technology as art to complete”, using conventional PCI techniques, but also applying new treatment techniques such as intravascular ultrasound (IVUS), coronary flow reserve (FFR), laser vascular tomography (OCT), and coronary plaque spinning and grinding, to improve the success rate of PCI and guarantee the patient’s The third is strict postoperative care and follow-up to prevent immediate and long-term complications of PCI and to minimize the rate of long-term coronary in-stent restenosis. This article is published with permission from Dr. Jian-Song Yuan.